Diagnosis, Risk Stratification, And Management Of Pulmonary Hypertension Of Sickle Cell Disease.
Key Points
Key Points
Observational studies have consistently shown that increased tricuspid regurgitant jet velocity (TRV) measured by Doppler echocardiography, an increased serum N-terminal pro–brain natriuretic peptide (NT-pro-BNP) level, and pulmonary hypertension measured by right heart catheterization are all independent risk factors for mortality in adults.
To reduce the variability and to improve the quality of care that patients with SCD receive, the ATS developed clinical practice guidelines to advise hematologists, pulmonologists, cardiologists, pediatricians, and internists about how to identify and manage patients with SCD who are at increased risk for mortality.
Diagnosis
...iagnosi...
...ratification guides clinical decision...
...risk for mortality is defined as a TRV â...
...Questions for Evaluation of Dyspne...
Figure 1. Proposed Algorithm for Evaluation of Pul...
...Echocardiogram of a Patient with Pulmonary Hype...
Treatment
...atment...
...ith SCD who have an increased risk for mort...
...nts with SCD who have an increased r...
...ients with SCD who have RHC-confirmed...
...tients with SCD who have elevated TRV...
...ients with SCD who have RHC-confirmed P...
...tients with SCD who have RHC-confirmed m...
...ents with SCD who have RHC-confirmed marked ele...
...MedicationsHaving trouble viewing table? Expand...